[Effectiveness of 3-drug therapy in patients with advanced ovarian cancer].
26 patients out of 48 (54%) with an advanced ovarian carcinoma (III and IV degree) treated in the first stage by means of Adriablastine, Cisplatin and Cyclophosphamide responded to the therapy. Complete remission was achieved in 24 patients (50%), and partial remission (PR) only in 2 patients. Four patients with CR in III degree agreed to another operation. These have lived 60, 40, 40 and 36 months after the surgery. The authors achieved significantly statistically better results of the therapy by means of the procedure presented in comparison with the effectiveness of two-drug chemotherapy without applying Cisplatin.
Kwaśniewska-Rokicińska
C
C
Kaleta
B
B
Kumor-Głodny
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin
Skuteczność chemioterapii trójlekowej u chorych na zaawansowanego raka jajnika.